Atrophy-related inflammation CSF markers predict clinical progression in genetic frontotemporal dementia

Neuroinflammation is increasingly recognised as a key contributor to frontotemporal dementia (FTD) pathophysiology, yet how inflammatory processes relate to neurodegeneration and clinical progression remains poorly defined. This study aimed to identify a multivariate cerebrospinal fluid (CSF) inflammatory signature covarying with brain atrophy, and to determine its relevance to clinical and cognitive outcomes in genetic FTD. We recruited 234 participants (non-carrier controls n=78, presymptomatic carriers n=115, symptomatic carriers n=41) with CSF, MRI, and clinical (CDR (r) + NACC FTLD sum of boxes [CDR-SB]) and executive (Wechsler Adult Intelligence Scale-Revised Digit Symbol Substitution Task [DSST] assessments. A regularised canonical correlation analysis (rCCA) was used to derive a shared protein-brain covariance axis. Participants were followed annually for up to 8.6 years (CDR-SB) and 11.5 years (DSST), and linear mixed-effects models were used to estimate individual rates of clinical progression (CDR slope) and executive decline (DSST slope). The predictive value of the inflammation- and MRI-based profiles for cross-sectional CDR-SB, CDR slope, DSST and DSST slope were tested in linear models. Due to floor effects and violations of parametric assumptions, Bias-corrected and accelerated (BCa) confidence intervals (CI) and bootstrap CIs (95%, 5000 replicates) were utilised as the primary inferential criterion in the 2nd-level linear models; effects were considered non-significant if the 95% BCa CI crossed zero. The rCCA identified a robust inflammation-brain axis (r=0.89, p<0.001), driven by CXCL9, FLT3L, CCL3, and frontotemporal-insular atrophy pattern. In symptomatic carriers, the MRI canonical variate was associated with CDR-SB (beta=3.80, CI: [0.64, 6.20]) at baseline, whereas the inflammatory protein canonical variate was predictive of CDR-SB slope (beta=0.24, CI: [0.02, 0.46]). Whereas both MRI (beta= -7.27, CI:[-14.20, -1.00]) and protein (beta= -7.83, CI:[-14.00, -2.16]) canonical variates were linked to DSST cross-sectionally, but not longitudinally. No significant associations were found in pre-symptomatic carriers or non-carrier controls. A data-driven CSF inflammatory signature, covarying with frontotemporal-insular atrophy, tracks with clinical severity and cognitive impairment in people with genetic FTD, highlighting inflammation as a candidate therapeutic target and progression biomarker in the earliest clinically manifest stages of disease.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-11-12
DOI
https://doi.org/10.64898/2026.11.10.26367702
Primary Topic
Dementia and Cognitive Impairment Research
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Atrophy-related inflammation CSF markers predict clinical progression in genetic frontotemporal dementia

John Cornelis Van Swieten, Maura Malpetti, Emily G. Todd, Caroline Graff et al.
medRxiv
Dementia and Cognitive Impairment Research
preprint

Atrophy-related inflammation CSF markers predict clinical progression in genetic frontotemporal dementia

John Cornelis Van Swieten, Maura Malpetti, Emily G. Todd, Caroline Graff, Raffaella Migliaccio, Maria Carmela Tartaglia, Tobias Christoph Langheinrich, Eino Solje, James Benedict Rowe, Alexander Gerhard, Matthis Synofzik, Johannes Levin, Johanna Krüger, Eve Ferry‐Bolder, Isabelle Le Ber, Giancarlo Logroscino, Péter Körtvelyessy, Ignacio Illán‐Gala, Harro Seelaar, Jonathan D. Rohrer, Noah Lorenz Shapiro, Željko Uzelac, Phoebe H. Foster, Rose Bruffaerts, Arabella Bouzigues, Isabel J. Santana, Lize Corrine Jiskoot, Martina Bocchetta, Lucy Louise Russell, Markus Otto, Rik R. Vandenberghe, Maxime Bertoux, Kei Onn Lai, Peter Simon Jones, Kamen A. Tsvetanov, Daniela Galimberti, Thibaud Lebouvier, Mario Masellis, Robert Jr Laforce, Rhian S. Convery, Giuseppe Di Fede, Barbara Borroni, Fermín Moreno, Simon Ducharme, M. Schroeter, Benedetta Nacmias, Alexander Thompson, Alexandre Mendonca, Sophie Farley, Eva Cullen, Raquel Sanchez‐Valle, Meira van Schaik, Elizabeth Finger, Genetic FTD Initiative
preprint en

Abstract

Neuroinflammation is increasingly recognised as a key contributor to frontotemporal dementia (FTD) pathophysiology, yet how inflammatory processes relate to neurodegeneration and clinical progression remains poorly defined. This study aimed to identify a multivariate cerebrospinal fluid (CSF) inflammatory signature covarying with brain atrophy, and to determine its relevance to clinical and cognitive outcomes in genetic FTD. We recruited 234 participants (non-carrier controls n=78, presymptomatic carriers n=115, symptomatic carriers n=41) with CSF, MRI, and clinical (CDR (r) + NACC FTLD sum of boxes [CDR-SB]) and executive (Wechsler Adult Intelligence Scale-Revised Digit Symbol Substitution Task [DSST] assessments. A regularised canonical correlation analysis (rCCA) was used to derive a shared protein-brain covariance axis. Participants were followed annually for up to 8.6 years (CDR-SB) and 11.5 years (DSST), and linear mixed-effects models were used to estimate individual rates of clinical progression (CDR slope) and executive decline (DSST slope). The predictive value of the inflammation- and MRI-based profiles for cross-sectional CDR-SB, CDR slope, DSST and DSST slope were tested in linear models. Due to floor effects and violations of parametric assumptions, Bias-corrected and accelerated (BCa) confidence intervals (CI) and bootstrap CIs (95%, 5000 replicates) were utilised as the primary inferential criterion in the 2nd-level linear models; effects were considered non-significant if the 95% BCa CI crossed zero. The rCCA identified a robust inflammation-brain axis (r=0.89, p<0.001), driven by CXCL9, FLT3L, CCL3, and frontotemporal-insular atrophy pattern. In symptomatic carriers, the MRI canonical variate was associated with CDR-SB (beta=3.80, CI: [0.64, 6.20]) at baseline, whereas the inflammatory protein canonical variate was predictive of CDR-SB slope (beta=0.24, CI: [0.02, 0.46]). Whereas both MRI (beta= -7.27, CI:[-14.20, -1.00]) and protein (beta= -7.83, CI:[-14.00, -2.16]) canonical variates were linked to DSST cross-sectionally, but not longitudinally. No significant associations were found in pre-symptomatic carriers or non-carrier controls. A data-driven CSF inflammatory signature, covarying with frontotemporal-insular atrophy, tracks with clinical severity and cognitive impairment in people with genetic FTD, highlighting inflammation as a candidate therapeutic target and progression biomarker in the earliest clinically manifest stages of disease.

medRxiv
Western University (CA), Montreal Neurological Institute and Hospital (CA), Centre National de la Recherche Scientifique (FR), Sunnybrook Health Science Centre (CA), Karolinska University Hospital (SE), University of Lisbon (PT), University of Antwerp (BE), Inserm (FR), University of Eastern Finland (FI), University of Toronto (CA), University of Milan (IT), MRC Cognition and Brain Sciences Unit (GB), Universität Ulm (DE), Université de Lille (FR), University of Cambridge (GB), Oulu University Hospital (FI), Salford Royal NHS Foundation Trust (GB), German Center for Neurodegenerative Diseases (DE), McGill University Health Centre (CA), Hospital de Sant Pau (ES), Erasmus MC (NL), Hospitais da Universidade de Coimbra (PT), Cambridge University Hospitals NHS Foundation Trust (GB), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Karolinska Institutet (SE), University of Manchester (GB), Centre Hospitalier Universitaire de Lille (FR), LMU Klinikum (DE), Sorbonne Université (FR), University of Oxford (GB), Biomedical Research Networking Center on Neurodegenerative Diseases (ES), Kuopio University Hospital (FI), Assistance Publique – Hôpitaux de Paris (FR), Biogipuzkoa Health Research Institute (ES), Antwerp University Hospital (BE), Salford Royal Hospital (GB), Munich Cluster for Systems Neurology (DE), Centro San Giovanni di Dio Fatebenefratelli (IT), Centro de Investigación Biomédica en Red (ES), Pitié-Salpêtrière Hospital (FR), UK Dementia Research Institute (GB), Max Planck Institute for Human Cognitive and Brain Sciences (DE), Donostiako Unibertsitate Ospitalea (ES), Hertie Institute for Clinical Brain Research (DE), Institut du Cerveau (FR), VIB-KU Leuven Center for Brain & Disease Research (BE), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Fondazione IRCCS Istituto Neurologico Carlo Besta (IT), Université Laval (CA), Institut de Recerca Sant Pau (ES), Lille Neurosciences & Cognition (FR), Sunnybrook Research Institute (CA), Centro de Neurociências e Biologia Celular (PT), Northern Care Alliance NHS Foundation Trust (GB), UCL Queen Square Institute of Neurology (GB), University of Florence (IT), University College London (GB), Imperial College London (GB), McGill University (CA), University of Bari Aldo Moro (IT), Brunel University of London (GB), University of Duisburg-Essen (DE), Universitat de Barcelona (ES), University of Coimbra (PT), Charité - Universitätsmedizin Berlin (DE), University of Brescia (IT), University of Tübingen (DE), Ludwig-Maximilians-Universität München (DE), Hasselt University (BE), Medical Research Council (GB), Leipzig University (DE), University of Oulu (FI), KU Leuven (BE)
Wellcome Trust
Good health and well-being
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon